Thomas Balligand

427 total citations
12 papers, 146 citations indexed

About

Thomas Balligand is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Thomas Balligand has authored 12 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Thomas Balligand's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (3 papers) and CAR-T cell therapy research (2 papers). Thomas Balligand is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (3 papers) and CAR-T cell therapy research (2 papers). Thomas Balligand collaborates with scholars based in Belgium, United States and France. Thomas Balligand's co-authors include Vincent Stroobant, Maria Veiga‐da‐Cunha, Emile Van Schaftingen, Stefan N. Constantinescu, Hidde L. Ploegh, C. Pecquet, Didier Colau, Jean‐Philippe Defour, Xin Liu and Emilie Leroy and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Thomas Balligand

11 papers receiving 146 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Balligand Belgium 6 70 66 45 22 19 12 146
K R Reynolds United States 5 66 0.9× 72 1.1× 104 2.3× 15 0.7× 12 0.6× 10 190
Amélie Bonaud France 8 114 1.6× 36 0.5× 41 0.9× 11 0.5× 69 3.6× 15 210
Martin D. Kafina United States 6 126 1.8× 23 0.3× 36 0.8× 29 1.3× 12 0.6× 8 190
Sergiy Klymenko Ukraine 8 81 1.2× 24 0.4× 29 0.6× 10 0.5× 5 0.3× 25 134
Heather C. Murray Australia 7 99 1.4× 25 0.4× 55 1.2× 7 0.3× 34 1.8× 17 210
Kenneth Anderson United States 7 75 1.1× 24 0.4× 125 2.8× 12 0.5× 9 0.5× 14 205
Lia Liefaard United Kingdom 6 162 2.3× 44 0.7× 12 0.3× 12 0.5× 20 1.1× 11 231
Martyn Ronald Schaafsma Netherlands 6 62 0.9× 70 1.1× 28 0.6× 7 0.3× 48 2.5× 11 176
Salvatore Casciaro Italy 9 110 1.6× 67 1.0× 82 1.8× 7 0.3× 27 1.4× 14 183
Hayley A. Hanby United States 5 41 0.6× 26 0.4× 43 1.0× 5 0.2× 42 2.2× 11 145

Countries citing papers authored by Thomas Balligand

Since Specialization
Citations

This map shows the geographic impact of Thomas Balligand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Balligand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Balligand more than expected).

Fields of papers citing papers by Thomas Balligand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Balligand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Balligand. The network helps show where Thomas Balligand may publish in the future.

Co-authorship network of co-authors of Thomas Balligand

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Balligand. A scholar is included among the top collaborators of Thomas Balligand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Balligand. Thomas Balligand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Liu, Xin, et al.. (2025). Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy. Nature Biomedical Engineering. 10(1). 39–55. 1 indexed citations
3.
Balligand, Thomas, et al.. (2024). Nanobody-based CAR NK cells for possible immunotherapy of MICA+ tumors. PNAS Nexus. 3(5). pgae184–pgae184. 8 indexed citations
4.
Defour, Jean‐Philippe, Emilie Leroy, Thomas Balligand, et al.. (2023). Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers. eLife. 12. 3 indexed citations
5.
Liu, Xin, et al.. (2023). An armed anti-immunoglobulin light chain nanobody protects mice against influenza A and B infections. Science Immunology. 8(84). eadg9459–eadg9459. 12 indexed citations
6.
Balligand, Thomas, Harini Nivarthi, Stefan Kubicek, et al.. (2020). Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor. Blood. 137(14). 1920–1931. 5 indexed citations
7.
Balligand, Thomas, Younès Achouri, C. Pecquet, et al.. (2019). Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development. Leukemia. 34(2). 510–521. 32 indexed citations
8.
Leroy, Emilie, Thomas Balligand, C. Pecquet, et al.. (2019). Differential effect of inhibitory strategies of the V617 mutant of JAK2 on cytokine receptor signaling. Journal of Allergy and Clinical Immunology. 144(1). 224–235. 18 indexed citations
9.
Leroy, Emilie, Thomas Balligand, & Stefan N. Constantinescu. (2018). JAK2 V617F Dimerizes Homodimeric Cytokine Receptors Cytosolic Domains By Requiring Pseudokinase Domain Residues That Promote JAK2 Dimerization and Oncogenic Activity. Blood. 132(Supplement 1). 50–50. 1 indexed citations
10.
Pasquier, Florence, Caroline Marty, Thomas Balligand, et al.. (2017). New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis. Haematologica. 103(4). 575–586. 13 indexed citations
11.
Balligand, Thomas, Younès Achouri, Ilyas Chachoua, et al.. (2016). Crispr/Cas9 Engineered 61bp Deletion in the Calr Gene of Mice Leads to Development of Thrombocytosis. Blood. 128(22). 4274–4274. 3 indexed citations
12.
Veiga‐da‐Cunha, Maria, et al.. (2012). Molecular Identification of Hydroxylysine Kinase and of Ammoniophospholyases Acting on 5-Phosphohydroxy-l-lysine and Phosphoethanolamine. Journal of Biological Chemistry. 287(10). 7246–7255. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K R Reynolds Breakdown of academic impact, for papers by Amélie Bonaud Breakdown of academic impact, for papers by Martin D. Kafina Breakdown of academic impact, for papers by Sergiy Klymenko Breakdown of academic impact, for papers by Heather C. Murray Breakdown of academic impact, for papers by Kenneth Anderson Breakdown of academic impact, for papers by Lia Liefaard Breakdown of academic impact, for papers by Martyn Ronald Schaafsma Breakdown of academic impact, for papers by Salvatore Casciaro Breakdown of academic impact, for papers by Hayley A. Hanby
Rankless by CCL
2026